Mark A. Berman

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Leslie Miller, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Berman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Better Therapeutics, Inc. Chief Medical Officer Common Stock 448,140 $76,139 $0.1699 18 Dec 2023 Direct

Insider Reports Filed by Mark A. Berman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017023071936-berman-mark-a-2023-12-18 Better Therapeutics, Inc. 18 Dec 2023 1 $0 4 Chief Medical Officer 20 Dec 2023, 17:10
/report/000095017023035684-berman-mark-a-2023-07-27 Better Therapeutics, Inc. 27 Jul 2023 1 +$40,000 4 Chief Medical Officer 31 Jul 2023, 07:59
/report/000095017023013896-berman-mark-a-2023-03-01 Better Therapeutics, Inc. 01 Mar 2023 2 $0 4 Chief Medical Officer 21 Apr 2023, 18:13
/report/000089924322013361-berman-mark-a-2022-04-01 Better Therapeutics, Inc. 01 Apr 2022 1 $0 4 Chief Medical Officer 04 Apr 2022, 16:43
/report/000089924321042227-berman-mark-a-2021-10-28 Better Therapeutics, Inc. 28 Oct 2021 0 $0 3 Chief Medical Officer 01 Nov 2021, 20:28